What: Amid growing interest in testosterone for treating various menopausal symptoms—from mood improvement to increased libido—experts urge caution.
Key line: [Details not provided].
Source: New York Times.
New data shows fertilizing 7–9 eggs is ideal for live births and minimizing excess embryos.
Report finds mortality jumped in Texas post-ban; researchers call it a canary in the coal mine.
Breast pump startup Willow takes over UK-based Elvie’s assets, signaling tough market conditions for women’s health companies.
A small increase in births among women in their 30s and 40s offsets younger declines.
Women’s health startups raised $2.6B in VC funding last year, but exits remain elusive.
A major study ties maternal diabetes to neurodevelopmental issues in children.
Bladder-leak brand Poise proposes using pads for hormone testing in rural areas.
New GLP-1 pill for diabetes patients shows 7%+ weight loss, boosting Eli Lilly stock.
Women who start menopause before age 40 may face faster cognitive decline.
Researchers call for standardized criteria to assess dangerous placenta conditions.
Guardian report details how U.S. medical trainees are seeking abortion education abroad.
Cancer incidence among women continues to rise despite overall progress.
Even with dye bans, ultra-processed food remains the real issue, The Atlantic argues.
ADF targets birth control and IUD coverage in campaign to cut ties with ACOG.
WHI funding restored after backlash; $140 saved for every dollar spent, researchers say.
A new study finds fasting three days a week more effective than daily calorie restriction for weight loss.
Study finds no mass OBGYN flight from states with abortion bans—yet.
The influential Women’s Health Initiative will shut down without federal support.
Study finds no mass OBGYN flight from states with abortion bans—yet.
New Yorker review highlights how fetal rights are becoming the next legal front.